House ·
Health and Human Services
Hearing: on Tuesday, February 11, 2025 at 1:30 PM
Bills heard
| Number | Title | Status |
|---|---|---|
| HB 2218 | Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act. | House action |
Testimony
Unspecified (6)
-
Alexandra Blasi
— Kansas Board of Pharmacy
A03 HB2218
-
James Davis
— Private Citizen
A02 HB2218
-
Tess Bettler
— Compass Pathways
A01 HB2218
-
Tess Bettler
— Compass Pathways
A01 HB2218
-
James Davis
— Private Citizen
A02 HB2218
-
Alexandra Blasi
— Kansas Board of Pharmacy
A03 HB2218